Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content

Wegovy HD (semaglutide 7.2 mg) — GLP-1 receptor agonist FDA-approved for chronic weight management (bmi >=30, or >=27 with at least one weight-related comorbidity) from Novo Nordisk.

HomeMedicationsWegovy HD

GLP-1 receptor agonist

Wegovy HD

semaglutide 7.2 mgGLP-1injectionchronic weight management (bmi >=30, or >=27 with at least one weight-related comorbidity)

Generic name: semaglutide 7.2 mg · Novo Nordisk

Updated June 6, 2026

See top Wegovy HD providers

Affiliate disclosure: we earn commission on signups via partner provider links. Editorial ranking stays independent.

Slows digestion

Food sits in the stomach longer, so smaller portions feel full

Reduces appetite signals

Brain receptors quiet the food-reward loop — what patients call lower "food noise"

Improves blood-sugar control

Stimulates insulin after meals; lowers glucagon production

Wegovy HD (semaglutide 7.2 mg) — GLP-1 receptor agonist medication for chronic weight management
Photo: Unsplash

List price

$1349.00

/month, cash, no insurance

Form

Weekly injection

subcutaneous

Looking for a Wegovy HD prescriber?

See top GLP-1 providers

Medically reviewed

Wegovy HD is a GLP-1 receptor agonist approved for chronic weight management (bmi >=30, or >=27 with at least one weight-related comorbidity). Evidence is from FDA prescribing information and peer-reviewed trials.
— Reviewed by Dr. Jane Novak, MD, MPH

Wegovy HD is a GLP-1 receptor agonist used for Chronic weight management (BMI >=30, or >=27 with at least one weight-related comorbidity).

Mechanism of action

BrainReduces hunger signalsLower reward response to foodStomachSlows gastric emptyingProlongs feeling of fullnessPancreasBoosts insulin after mealsLowers glucagon productionGLP-1 receptorEffect siteGLP-1 receptors in the brain, gut, and pancreas all respond to the same medication, producing the combined effect of less hunger, slower digestion, and better blood-sugar control.
How Wegovy HD works in the body. Mechanism shared across the GLP-1 receptor agonist class. Adapted from NEJM 2021 review (DOI:10.1056/NEJMoa2032183) and FDA prescribing information.

Last Revised — by Dr. Jane Novak, MD, MPH

Medically reviewed by Dr. Jane Novak, MD, MPH 8 min read Fact checked Editorial integrityUpdated Jun 6, 2026

Pick your plan tier + deductible status for a tier-average estimate. Tap to expand.

Check Wegovy HD against another medication

Already taking something else? Look up interactions.

Type a medication you currently take. We'll route you to the full interaction report — and you should still confirm with your prescriber before changing anything.

Powered by FDA prescribing information cross-references. Not medical advice — for anything serious, call your prescriber or 911.

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Wegovy HD drug information
Wegovy HD is a GLP-1 receptor agonist medication used for chronic weight management and/or type 2 diabetes.Photo: Unsplash

Why is Wegovy HD prescribed?

Wegovy HD is FDA-approved to treat:

  • Chronic weight management (BMI >=30, or >=27 with at least one weight-related comorbidity)

How it works

7.2 mg is the higher-dose maintenance step approved August 2025 for patients who tolerate 2.4 mg but need additional weight-loss benefit. Same active ingredient (semaglutide) as Wegovy 2.4 mg, three-fold higher weekly dose at maintenance.

“Wegovy HD works by mimicking a natural hormone — the result is slower digestion, reduced appetite, and better blood-sugar control. What matters most is how patients respond over months, not days.”
— Dr. Jane Novak, MD, MPH

Dosing schedule

FDA-label titration timeline for Wegovy HD. Doses ramp gradually to limit gastrointestinal side effects; never accelerate the schedule without prescriber input.

  1. Step 1

    1-4

    0.25 mg

  2. Step 2

    5-8

    0.5 mg

  3. Step 3

    9-12

    1.0 mg

  4. Step 4

    13-16

    1.7 mg

  5. Step 5

    17-20

    2.4 mg

  6. Step 6

    21-24

    4.0 mg

  7. Step 7

    25+

    7.2 mg

    Maintenance

Source: FDA prescribing information. Weekly subcutaneous injection. Dose escalation may be delayed if side effects are intolerable. Doses listed here are typical; your prescriber may adjust based on tolerance and response.

Titration schedule

Weekly dose progression

Each escalation holds 4 weeks before the next step up — standard pattern across GLP-1 weight-management labels.

7.2 mg5.4 mg3.6 mg1.8 mg0 mg0.25 mg0.5 mg1.0 mg1.7 mg2.4 mg4.0 mg7.2 mgWk 1Wk 5Wk 9Wk 13Wk 17Wk 21Wk 25

Other reported reactions

Nausea
commonmild
Vomiting
commonmoderate
Diarrhea
commonmild
Constipation
commonmild
Pancreatitis
raresevere
Gallbladder disease
uncommonmoderate

Use & safety

Pregnancy

Discontinue >=2 months before planned pregnancy

Breastfeeding

Avoid, secretion into human milk unknown

Missed dose

If missed by <=5 days, inject as soon as possible. If missed by >5 days, skip and resume next scheduled dose.

Storage

Refrigerate 2-8 C unopened. After first use: room temp up to 28 days.

More on Wegovy HD

How to inject Wegovy HDWegovy HD side effectsQuestions to ask your doctor

Reader reviews

Verified user experiences with Wegovy HD. Reviews are moderated before publishing.

No user reviews yet

Be the first to share what worked — side effects, titration experience, dosing, weight-loss timeline. The form below takes ~2 minutes.

Share your experience with Wegovy HD

Real-world experiences help others. We moderate every review before publishing.

Your rating

By submitting, you agree we may publish the rating, title, body, "months used" tag, and your name (if provided). Your email stays private.

Sources & further reading

All clinical claims on this page are sourced from the FDA prescribing information and peer-reviewed literature. Verify the most current label before clinical decisions.

See our data sources of truth and the consolidated references bibliography for every claim cited above.

Related medications

Other drugs in the same class — GLP-1 receptor agonist.

Ozempic

semaglutide

~$997.58/mo

View details

Wegovy

semaglutide

~$1349.02/mo

View details

Ozempic

semaglutide

~$935.77/mo

View details

Side-effect timeline

peaks fade

Typical 16-week titration schedule. Individual experience varies — track yours with the printable tracker.

  1. 1

    Wk 1-2

    First injection

    • NauseaModerate
    • FatigueModerate
    • BloatingMild

    Peak nausea — eat small protein-forward meals; hydrate.

  2. 2

    Wk 3-4

    Body adapting

    • NauseaMild
    • ConstipationModerate
    • RefluxMild

    Constipation climbs as GI motility slows. Add fiber + magnesium.

  3. 3

    Wk 5-8

    Dose escalation #1

    • NauseaModerate
    • FatigueMild
    • DiarrheaMild

    Symptoms re-spike for ~7 days after each escalation.

  4. 4

    Wk 9-12

    Settling in

    • NauseaMild
    • RefluxMild

    GI complaints meaningfully fade. Weight loss accelerates.

  5. 5

    Wk 13-16

    Maintenance ramp

    • Mild fatigueMild
    • Hair sheddingMild

    Hair shedding from rapid weight loss may appear (resolves by month 6).

  6. 6

    Wk 17+

    Maintenance

    • Generally well-toleratedNone

    Most side effects resolved. Watch for gallbladder symptoms long-term.

Frequencies and timing aggregated from FDA prescribing information (Wegovy, Zepbound, Mounjaro, Ozempic) and the STEP/SURMOUNT trial datasets.

Drugs in the same class

GLP-1 receptor agonist alternatives

  1. Ozempicsemaglutidefrom $935.77/mo
  2. Ozempicsemaglutidefrom $997.58/mo
  3. Wegovysemaglutidefrom $1,349.02/mo

6 ways to save

Ways to actually pay less for this medication

Stacking two of these typically cuts more than a single savings card alone. Eligibility is program-specific; every link goes to the official source so you can verify.

  • Manufacturer savings card

    Novo Nordisk's Wegovy Savings Offer and Lilly's Zepbound Savings Card reduce commercially-insured patients' copays. Eligibility excludes Medicare / Medicaid / Tricare. Terms and dollar amounts change quarterly — confirm on the brand site before signup.

    Open program page →

    Verified 2026-06-01

  • HSA or FSA

    GLP-1 medications prescribed for an IRS-qualified condition (T2D / chronic weight management with prescriber documentation) are eligible for HSA / FSA reimbursement. Use pre-tax dollars; save your invoices for substantiation.

    Open tool →

    Verified 2026-06-01

  • Patient-assistance programs

    Novo Nordisk PAP and Lilly Cares offer drug at no or reduced cost to qualified uninsured / underinsured patients. Income-tested; clinician submits the form. Approval windows are 30-90 days.

    Open program page →

    Verified 2026-06-01

  • Medicare Extra Help (LIS)

    Federal Medicare law has historically excluded weight-loss agents; 2024 CMS rulemaking is evolving. For T2D indications (Ozempic, Mounjaro, Rybelsus) Extra Help can cover most cost when the drug is on your Part D formulary. Check Medicare.gov for current status.

    Open program page →

    Verified 2026-06-01

  • Tax deduction angle

    Out-of-pocket prescription costs exceeding 7.5% of adjusted gross income are deductible on Schedule A. Save every receipt; pair with HSA for the strongest tax stack. Talk to a tax professional for your situation.

    Open program page →

    Verified 2026-06-01

  • Cheapest cash-pay channel

    Telehealth providers' cash-pay tiers (compounded routes; brand via savings card) routinely beat retail pharmacy cash. Compare current monthly cost on our ranking — prices updated monthly.

    Open tool →

    Verified 2026-06-01

Editorial: we earn no commission on government-program signups. Cash-pay channel links use tracked /go redirects to affiliated telehealth providers — see disclosure. Savings-program terms change frequently — confirm dollar amounts and eligibility on each official page before signup. Each card shows the last date our editorial team confirmed the link.

What to expect

Your first month on Wegovy HD, day by day

Editorial composite — your prescriber's protocol may differ. Individual timelines vary; call your prescriber if symptoms intensify rather than ease.

  1. Days 1-3

    First injection, mild appetite shift

    Most patients notice subtler hunger cues within 48-72 hours. Some experience mild nausea — eat smaller, lower-fat meals; hydrate consistently.

  2. Days 4-7

    Side effects peak then ease

    Mild GI side effects (nausea, soft stool, fatigue) typically peak around day 4-5 then settle. If they intensify, contact your prescriber before stepping up.

  3. Weeks 2-4

    Steady dose, adapting body

    You stay at the starter dose for 4 weeks before the first step-up. Hunger and cravings continue declining; energy normalizes for most.

  4. Week 5+

    First dose escalation

    Your prescriber steps you up to the next dose tier per the FDA label. Expect a brief return of GI side effects for 3-7 days as your body re-adapts.

  5. Month 2+

    Therapeutic dose territory

    By week 9 most patients reach a therapeutic dose. Visible weight change usually appears 4-6 weeks after this point. Track progress monthly; do not weigh daily.

Your prescriber may slow any step where side effects are still settling. See the FDA label for the official titration schedule for Wegovy HD.

What you're paying for

What's typically included in a Wegovy HD telehealth subscription

Editorial composite across affiliated providers. Per-provider breakdowns live on each provider page — terms vary.

  • Licensed clinician visit

    Initial asynchronous or video consult with a clinician licensed in your state. Eligibility, dosing, and any contraindications reviewed against your intake.

  • Medication, shipped

    Brand or compounded GLP-1 prescription dispensed by a US-licensed pharmacy and shipped temperature-controlled to your address.

  • Ongoing care messaging

    Async clinician messaging for side-effect management, dose-step questions, and refill timing. Most providers respond within one business day.

  • Refills + cost adjustments

    Automatic refill scheduling tied to your dose cadence; price re-priced monthly when manufacturer programs or program tiers change.

Lab work, consult re-runs, and certain tier upgrades may incur additional cost depending on provider — confirm on the provider page before signup.

Was this page helpful?